市场调查报告书
商品编码
1248113
全球消融设备市场——按技术、应用、最终用途和预测划分,2023-2032 年Ablation Devices Market - By Technology, By Application, By End-use & Global Forecast, 2023 - 2032 |
全球消融设备市场预计将从 2023 年到 2032 年显着增长,这要归功于该行业不断创新以提高准确性并提供更好的结果。
2023年,i-VASC宣布首次临床使用VELEX,这是一种用于治疗慢性静脉功能不全的空静脉消融技术设备。
这些企业集团还投资于研发活动以开发和推出新产品,从而提高了产品供应率。 例如,2023年2月,雅培的两款电生理产品在欧美获得监管批准,用于治疗心房颤动等心律失常患者,一款带有尖端和接触力感应的消融导管获得CE标誌(AFib)。
该公司还声称,TactiFlex 消融导管 SE 可以更轻鬆地适应心臟组织,同时提供高功率消融治疗。 与传统的功率消融相比,它已被证明可以减少手术时间和患者的辐射暴露。
消融设备行业按技术、应用、最终用途和地理位置进行细分。
就技术而言,到 2032 年,激光/光学烧蚀行业的价值预计将超过 21 亿美元。 发达国家和发展中国家老龄化人口的持续增加预计将增加对激光/光消融设备的需求。 与使用激光消融设备相关的主要优势,例如高效性和安全性,也将推动这一领域的增长。
根据应用,预计眼科领域在估计期间的复合年增长率将超过 9%。 2023 年至 2032 年期间,技术的不断发展和先进设备的普及以及为各种眼疾提供治疗的设备齐全的设施将推动该领域的扩张。
考虑到最终用途,预计其他部分在预测期内将显着增长。 其他部门包括独立的导管实验室、诊所、多学科中心和消融中心。 对为一系列医疗条件提供专门治疗和高质量护理的多专科中心的需求正在增加,我们预计到 2032 年底该行业将获得发展势头。
按地区划分,到 2032 年,欧洲消融设备行业的价值预计将超过 55 亿美元。 易患慢性病的老年人口不断增加,推动了该地区对消融设备的需求。 此外,可支配收入的增加和创新技术的采用预计将在预计期间进一步推动欧洲消融设备市场的增长。
Ablation Devices Market is estimated to grow considerably during 2023-2032 owing to the constant technological innovations in the industry to offer enhanced precision and better outcomes. In 2023, I-VASC announced the 1st clinical use of VELEX, the Empty Vein Ablation technology device for chronic venous insufficiency treatment.
These conglomerates are also investing in research and development activities for new product development and launches, thus positively expanding the product availability ratio. For instance, in February 2023, regulatory approval was granted for two of Abbott's electrophysiological products in Europe and the U.S. for treating patients with irregular cardiac rhythms like atrial fibrillation, Abbott's Sensor Enabled TactiFlex Ablation Catheter, an ablation catheter with an adaptable tip and contact force sensing, received the CE mark (AFib).
Also, according to the company, the TactiFlex Ablation Catheter SE can give high-power ablation treatment while more readily adjusting to the heart tissue. It has been demonstrated to shorten operation times and patient radiation exposure compared to traditional power ablation.
Overall, the ablation device industry is segmented in terms of technology, application, end-use and region.
Based on technology, the laser/light ablation segment is anticipated to be valued at over USD 2.1 billion by 2032. The constantly growing geriatric population base in developed and developing nations is expected to push the demand for laser/light ablation devices. In addition, key advantages linked with using laser ablation devices, such as high efficacy and safety, will also drive the segmental growth.
By application, the ophthalmology segment will depict over 9% CAGR during the estimated timeframe. Constant technological developments and budding adoption of advanced devices and well-equipped facilities that offer treatment for a wide range of ophthalmic diseases will drive the segment expansion between 2023-2032.
Considering the end-use, the others segment will grow considerably during the forecast period. Independent catheterization laboratories, physician's offices, multispecialty centers, and ablation centers are covered under the other segment. Increasing demand for multispecialty centers owing to their provision to offer specialized treatment for various medical conditions and superior quality of medical care will help the segment gain momentum through 2032 end.
Regionally, the Europe ablation device industry will be valued at over USD 5.5 billion by 2032. An increasing geriatric population base that is more susceptible to chronic diseases will stimulate the demand for ablation devices across the region. In addition, rising disposable income and high adoption of innovative technologies will further drive the European ablation devices market growth over the estimated timeframe.